Lundbeck Receives FDA Fast Track Designation for Narcolepsy Candidate Lu AH69593

Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company's lead oral orexin 2 rece...

July 27, 2026 | Monday | News
Fresenius Launches €200 Million Venture Fund to Invest in Healthcare Innovation

The issuer is solely responsible for the content of this announcement. Fresenius is further expanding its access to innovation networks through its own co...

July 27, 2026 | Monday | News
Synaptiq Therapeutics Launches to Advance SYN-001 for 22q11DS Neuropsychiatric Symptoms

A consortium of European and US-based investors and Nobias Therapeutics announced the launch of Synaptiq Therapeutics, a privately held, clinical-stage bio...

July 27, 2026 | Monday | News
arcoris bio Partnered with Europa Biosite to Expand immunoMUSE® Kit Distribution

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, announced a distribution partnership with Europa Biosite, a leading di...

July 23, 2026 | Thursday | News
Samsung Biologics Announced CHF 1.46 Billion Tender Offer to Acquire PolyPeptide

  Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding ...

July 21, 2026 | Tuesday | News
Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, announced the expansion of its mu...

July 20, 2026 | Monday | News
Dana-Farber, OSUCCC–James and IBCRF Launch Collaborative Research Initiative for Metastatic Inflammatory Breast Cancer

In a significant move to advance the treatment of patients with inflammatory breast cancer (IBC), Dana-Farber Cancer Institute, The Ohio State Univ...

July 20, 2026 | Monday | News
Roche Launches cobas HDV Test for Automated Hepatitis D Diagnosis and Monitoring

The new test enables clinicians to reliably diagnose HDV and monitor patients’ treatment response. Hepatitis D  affects nearly 12 million o...

July 15, 2026 | Wednesday | News
Sanofi Wins FDA Approval for Subcutaneous Sarclisa Escena with On-Body Injector

Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena admini...

July 14, 2026 | Tuesday | News
What Future UK Regulation of AI in Healthcare Looks Like Now

  While we will need to wait for the National Commission into the Regulation of AI in Healthcare's recommendations later this summer, and then the MH...

July 14, 2026 | Tuesday | Expert Opinion
Vivani Medical Signs Agreement with Novo Nordisk to Evaluate NPM-139 Obesity Implant

Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), an innovative biopharmaceutical company specializing in the development of innovative dr...

July 13, 2026 | Monday | News
Danaher’s Abcam Partners with EpiCypher to Advance Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CU...

July 09, 2026 | Thursday | News
Genmab Secures European Approval for TEPKINLY Plus R2 as First Bispecific-Based Second-Line Follicular Lymphoma Therapy

TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of...

July 08, 2026 | Wednesday | News
Novartis to Acquire Myricx Bio in Up to $1.5 Billion Deal to Expand Next-Generation ADC Portfolio

Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of action Combines oncology expertise of ...

July 07, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close